RGDペプチド

細胞外マトリックスタンパク質など、多くの細胞接着性タンパク質に共通で保 存されている、Arg-Gly-Asp配列(RGD配列)を有する製品のリストです。
 
 
 

Code Compound
4171 Fibronectin Active Fragment (RGDS)
4171-v Fibronectin Active Fragment (RGDS)
4189 Fibronectin Active Fragment (GRGDS)
4189-v Fibronectin Active Fragment (GRGDS)
4304 cyclo(Arg-Gly-Asp-D-Phe-Val) Angiogenesis Inhibitor
4304-v cyclo(Arg-Gly-Asp-D-Phe-Val) Angiogenesis Inhibitor
4532 Cyclo(Arg-Gly-Asp-D-Phe-Lys) αvß3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide(Requires Further Derivatization Before Use)
4532-v Cyclo(Arg-Gly-Asp-D-Phe-Lys) αvß3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide(Requires Further Derivatization Before Use)
CAN-3505-PI H-[Lys-Leu-Ala-Lys-Leu-Ala-Lys]2-Gly-Phe-Leu-Gly-(Cys-Gln-Thr-Pro-Tyr-Tyr-Met-Asn-Thr-Cys)-OH Cell Penetrating Peptide (CPP). Targets EGFR, Binding to a Specific Protein in Carcinoma Cells, and Induces Apoptosis.
ECT-3760-PI Echistatin αVß3 Integrin Antagonist
FAP-3758-PI Fibronectin Adhesion-Promoting Peptide
PCA-3618-PI Cyclo(Arg-Ala-Asp-D-Phe-Val) Negative Control for 4304
PCI-3651-PI H-Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 αvß3 Integrin Binding RGD Peptide; RGD Tumor Targeting Peptide (Requires further derivatization before use)
PCI-3662-PI Cyclo(Arg-Gly-Asp-D-Tyr-Lys) αvß3 Integrin Binding RGD Peptide RGD Tumor Targeting and Tumor Imaging Peptide (Requires Further Derivatization Before Use)
PCI-3686-PI Cyclo(Arg-Gly-Asp-D-Phe-Cys) RGD Tumor Targeting Peptide (linker additions via Cys) (May Require Further Derivatization Before Use)
PCI-3687-PI Cyclo(Arg-Gly-Asp-D-Phe-Glu) RGD Peptide for Radiolabeling and Imaging (Requires Further Derivatization Before Use)
PCI-3688-PI Cyclo(Arg-Gly-Asp-D-Tyr-Glu) RGD Peptide for Radiolabeling (Requires further derivatization before use)
PCI-3696-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG)] RGD Peptide Equipped with PEG Spacers for More Efficient Binding to Lipid Surfaces(Requires Further Derivatization Before Use)
PCI-3697-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin-PEG-PEG)] RGD Peptide Equipped with a Biotin Reporting Tag and PEG Spacers for More Efficient Binding to Lipid Surfaces (Requires Further Derivatization Before Use)
PCI-3699-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Ac-SCH2CO)] RGD Peptide Equipped with Thioacetyl Group for Linking to Liposomes (May Require Further Derivatization and Deprotection Before Use)
PCI-3790-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(dPEG®4)] RGD Tumor Targeting (and With Radiolabeling, A Tumor Imaging Peptide)
PCI-3808-PI Cyclo[Arg-Ala-Asp-D-Phe-Lys(Biotin-PEG-PEG)] Negative Control Peptide for PCI-3697-PI
PCI-3823-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG-Cys)]
PCI-3861-PI Cyclo[Arg-Gly-Asp-D-Tyr-Lys(Cys-AEEA-DOTA)] RGD Peptide Functionalized with a Radiometal Chelator, DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid); Potentially Useful for Tumor Targeting and Imaging.
PCI-3883-PI Cyclo(Arg-Ala-Asp-D-Phe-Lys) Negative Control RGD Peptide for 4532
PCI-3894-PI Cyclo(Arg-Ala-Asp-D-Tyr-Lys) Control Peptide of cyclo (Arg-Gly-Asp-D-Tyr-Lys) (PCI-3662-PI)
PCI-3895-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin)] RGD Peptide Equipped with a Biotin Reporting Tag
PCI-3898-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(H-Ser)] αvß3 Integrin Binding RGD Peptide; RGD Tumor Targeting Peptide (Requires further derivatization before use)
PCI-3899-PI H-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 Tumor Targeting and Tumor Imaging Peptide (Requires Further Derivatization Before Use)
PCI-3903-PI DOTA-Glu-[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 αvß3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide for Radiolabelling (Requires further derivatization before use)
PCI-3904-PI H-Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 RGD Tumor Targeting and Tumor Imaging Peptide (Requires further derivatization before use)
PCI-3909-PI H-Gly-Arg-Gly-Asp-Asn-Pro-OH RGD peptide and Inhibitor of Cell Adhesion to Fibronectin
PCI-3910-PI H-Gly-Arg-Ala-Asp-Ser-Pro-OH Negative Control for Fibronectin Inhibitors
PCI-3912-PI Cyclo(Arg-Gly-Asp-D-Tyr-Cys)
PCI-3917-PI Cyclo(Arg-Ala-Asp-D-Tyr-Cys)
PCI-3919-PI Cyclo(Arg-Gly-Asp-D-Phe-Lys) RGD Tumor Targeting Peptide (Requires further derivatization before use)
PCI-3929-PI H-Arg-Gly-Asp-Ser-Lys-OH RGD Tumor-Targeting Peptide
PCI-3930-PI H-Arg-Ala-Asp-Ser-Lys-OH Negative Control for PLI-3929-PI
PCI-3953-PI Cyclo(Arg-Gly-Glu-D-Phe-Lys)
PCI-3954-PI Cyclo[Arg-Ala-Asp-D-Phe-Lys(PEG-PEG)] Negative Control Peptide for PCI-3696-PI
PCI-3959-PI Cyclo[Arg-Ala-Asp-D-Phe-Lys(Ac-SCH2CO)] Control for PCI-3699-PI
PCI-3960-PI Cyclo(Arg-Ala-Asp-D-Phe-Cys) Negative Control Peptide for PCI-3686-PI
PCI-3963-PI H-Pro-His-Ser-Arg-Asn-OH
PCI-3964-PI H-Gly-Asp-Gly-Val-D-Ile-Thr-Arg-Ile-Arg-OH CD36 Binding Peptide
PCI-3965-PI H-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Ser-Pro-OH
PCI-3975-PI H-Glu{Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2 Tetrameric RGD Peptide
PCI-3977-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-COCH2CH2SH)]
PCI-3979-PI H-Glu[Cyclo(Arg-Ala-Asp-D-Phe-Lys)]2 Negative Control Peptide for PCI-3651-PI
PFA-3907-PI H-Gly-Arg-Gly-Glu-Ser-OH Negative Control for 4189-v
PFA-3924-PI Ac-Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-(Gly)4-Ser-D-Arg-(Leu)6-D-Arg-NH2 Hydrophobic RGD Fibronectin Peptide
RGD-3000-PI Cyclo[Arg-Gly-Asp-D-Tyr-Lys(PEG)]
RGD-3005-PI Cyclo[Arg-Ala-Asp-D-Tyr-Lys(PEG)] Control peptide for RGD-3000-PI
RGD-3035-PI Ac-cyclo [Pen-Tyr(Me)-Ala-Arg-Gly-Asp-Asn-Tic-Cys]-NH2 Cell Penetrating Peptide That Targets EGFR, Binds to a Specific Protein in Carcinoma Cells, and Induces Apoptosis
RGD-3506-PI H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH Thiolated Cell Adhesion Peptide
RGD-3736-PI Galactosyl-Cyclo(Arg-Gly-Asp-D-Phe-Lys) Glycosylated RGD for Radiolabelling
RGD-3749-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Azide)] Clickable RGD for Dendrimer Constructs
RGD-3750-PI H-dPEG®4-Glu[dPEG®4(Cyclo(Arg-Gly-Asp-d-Phe-Lys))]2 For In Vitro Assays of Integrin αvß3/αvß5 Expression in Tumor Tissues
RGD-3759-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG-Azide)] Clickable RGD for Dendrimer Constructs
RGD-3761-PI H-[Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys]-NH2 RGD Tumor Targeting Peptide
RGD-3762-PI H-[Cys-Arg-Gly-Asp-Arg-Gly-Pro-Asp-Cys]-NH2 RGD Tumor Targeting Peptide
RGD-3766-PI H-AEEEA-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 Bicyclic RGD Peptide for Imaging
RGD-3782-PI Galacto-RGD2 Ddimer
RGD-3794-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Cys)] RGD Peptide for Radiolabeling and Imaging
RGD-3795-PI Cyclo[Arg-Gly-Asp-D-Phe-Lys(Mal)] RGD Peptide With 3-Maleimidopropionic Acid Functional Group
RGD-3842-PI Cyclo[Arg-Ala-Asp-D-Phe-Lys(Azide)] Negative Control Peptide for RGD-3749-PI
RGD-3879-PI N3-PEG-PEG3-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 Bicyclic RGD peptide Optimized for Click Chemistry
RGD-3993-PI Mal-PEG3-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 Dimeric RGD peptide for click chemistry


Scroll to top